Vistra Corp. (VST)
Live price chart, market sentiment, and community perspectives for Vistra Corp. (NYSE: VST).
Live price chart, market sentiment, and community perspectives for Vistra Corp. (NYSE: VST).
On our fundamental desk, VST looks fundamentally solid with adjusted EBITDA up to $1.8 billion in Q2, yet we are holding off on a buy upgrade. The valuation has compressed nicely with the forward PE dropping to roughly 16.9x–23.8x, but the 26.8% stock slide over the past year highlights ongoing investor skepticism over margin volatility and execution risks.
Analyzing the reported filings, the headline drop in Q2 net income to $305 million is largely an artifact of $472 million in unrealized mark-to-market losses on future hedges rather than poor core execution. Management has reaffirmed full-year 2026 adjusted EBITDA guidance of $6.8B to $7.6B, which keeps our baseline financial projections stable despite the near-term noise.
Our risk management assessment highlights that 2026 generation volumes are nearly fully hedged, which anchors cash flow expectations. However, softened ERCOT forward power prices and upcoming regulatory clearances for the $4.0 billion Cogentrix gas-fleet acquisition expected in H2 2026 introduce near-term event risks that warrant patience.
From a portfolio management perspective, the narrative has shifted away from viewing Vistra as a cyclical power producer toward pricing it as critical AI and data center infrastructure. Long-term nuclear power purchase agreements with AWS and Meta, alongside the Nvidia partnership, provide exceptional revenue visibility, though we need to see sustained cash flow realization before committing fresh capital.
On our options desk, we have observed sizable buying of out-of-the-money calls alongside strong technical support holding near recent lows. While PJM's 2028-29 auction clearing at the $325/MW-day cap secures roughly $1.30 billion in annualized capacity revenue, regulatory uncertainties and rising operating costs keep our risk-reward matrix strictly balanced at a Hold.
Explore plasma cleansing, somatic organ swaps, and BCI.